Loading the company…
Loading the company…
Families: Lumbar fusion, Cervical fusion & disc arthroplasty.
All companies · Product and company coverage
In the last ten years FDA made 20 decisions for Carlsmed (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2024 (7). The latest was on 2026-09-24.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 18 |
| Cervical fusion & disc arthroplasty | 5 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-09-24 | 510(k) | K262149 | corra® cervical plating system |
| 2026-05-09 | 510(k) | K260385 | aprevo® anterior and lateral lumbar interbody system; aprevo® posterior and transforaminal lumbar interbody system; aprevo® cervical interbody system; corra cervical plating system |
| 2026-04-22 | 510(k) | K260570 | corra cervical plating system |
| 2026-01-06 | 510(k) | K252894 | aprevo® cervical interbody system |
| 2025-12-22 |
In 2025, Carlsmed reported engagement with 426 surgeons and other clinicians in the states MedaRep covers, worth $753K in consulting, speaking, meals and travel for its device products, the most in California ($216K to 57). Royalties are left out.
| 510(k) |
| K252611 |
| aprevo® cervical plating system |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Carlsmed.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: California ($216K, 57 engaged), Florida ($192K, 107 engaged), New York ($55K, 7 engaged), Virginia ($53K, 8 engaged), Iowa ($50K, 1 engaged).